This report contains market size and forecasts of Cetuximab Biosimilar in global, including the following market information:
Global Cetuximab Biosimilar Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cetuximab Biosimilar Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Cetuximab Biosimilar companies in 2021 (%)
The global Cetuximab Biosimilar market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
100 mg/50 mL Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cetuximab Biosimilar include Actavis, Amgen, Celltrion, Pfizer, Bio X Cell, Wuhan Dima Biotechnology and Guangdong ANNPO Biotechnology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cetuximab Biosimilar manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cetuximab Biosimilar Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Cetuximab Biosimilar Market Segment Percentages, by Type, 2021 (%)
100 mg/50 mL Injection
200 mg/100 mL Injection
Global Cetuximab Biosimilar Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Cetuximab Biosimilar Market Segment Percentages, by Application, 2021 (%)
Metastatic colorectal cancer
Metastatic breast cancer
Non-small cell lung cancer
Other
Global Cetuximab Biosimilar Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Cetuximab Biosimilar Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cetuximab Biosimilar revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cetuximab Biosimilar revenues share in global market, 2021 (%)
Key companies Cetuximab Biosimilar sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Cetuximab Biosimilar sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Actavis
Amgen
Celltrion
Pfizer
Bio X Cell
Wuhan Dima Biotechnology
Guangdong ANNPO Biotechnology